Andrew Freeman
About
In The Last Decade
Andrew Freeman
17 papers receiving 376 citations
Peers
Comparison fields: 5 of 99
- Surgery 138
- Physiology 55
- Infectious Diseases 52
- Molecular Biology 48
- Pediatrics, Perinatology and Child Health 45
Countries citing papers authored by Andrew Freeman
This map shows the geographic impact of Andrew Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Freeman more than expected).
Fields of papers citing papers by Andrew Freeman
This network shows the impact of papers produced by Andrew Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Freeman. The network helps show where Andrew Freeman may publish in the future.
Co-authorship network of co-authors of Andrew Freeman
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Freeman. A scholar is included among the top collaborators of Andrew Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Freeman. Andrew Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 16 | |
| 3 | 64 | |
| 4 | 1 | |
| 5 | 35 | |
| 6 | 21 | |
| 7 | 2 | |
| 8 | 11 | |
| 9 | 5 | |
| 10 | 5-HT-3 receptor antagonists in the control of cisplatin-induced delayed emesis | 16 |
| 11 | 23 | |
| 12 | 4 | |
| 13 | 16 | |
| 14 | 70 | |
| 15 | Experience with ondansetron in chemotherapy- and radiotherapy-induced emesis. | 11 |
| 16 | 60 | |
| 17 | 2 | |
| 18 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.